Tag: Pie Medical

Pie Medical Imaging announces 500th patient in the FAST III clinical trial

MAASTRICHT, Netherlands, Jan. 20, 2023 /PRNewswire/ — Pie Medical Imaging, a global leader in cardiac imaging, announced the 500th patient inclusion in the FAST III, a multi-center randomized clinical trial, which investigates the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in patients undergoing coronary revascularization procedures. In this trial, a CAAS vFFR guided strategy is compared to a FFR […]

Pie Medical Imaging announces the global release of its latest echocardiography software technology, CAAS Qardia 2.0

MAASTRICHT, Netherlands, Jan. 13, 2023 /PRNewswire/ — Pie Medical Imaging (“PMI”), a global leader in cardiac imaging, today launched CAAS Qardia 2.0, a new version of their innovative echocardiography software platform. CAAS Qardia leverages artificial intelligence driven workflows for performing key clinical measurements and ease-of-access. The CAAS Qardia platform offers in-hospital deployment as so-called zero-footprint solution, meaning access from any PC within the […]

FASTII international multicenter trial confirms high diagnostic accuracy of Pie Medical Imaging CAAS vFFR solution

MAASTRICHT, Netherlands, May 19, 2021 /PRNewswire/ — Pie Medical Imaging (“PMI”), a global leader in cardiac imaging, today announced the conclusion of the FASTII trial and presentation of the results as a late breaking clinical trial at EuroPCR 2021. CAAS vFFR is an innovative technology allowing the non-invasive physiological assessment of coronary lesions. […]